跳至主要内容
临床试验/CTRI/2024/11/076392
CTRI/2024/11/076392尚未招募3 期

A Randomized controlled trial to evaluate the efficacy of Atosiban in patients undergoing Embryo transfer.

Sree Supriya M1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年11月12日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Biochemical Pregnancy rate

研究概览

简要总结

Women undergoing embryo transfer who fulfil the inclusion criteria are selected and divided into two groups - the first group given the full dose - bolus dose followed by continuous intravenous infusion of 18 mg at the rate of 20 drops/min for an hour and 6 drops/min for next 2 hours and the second group proceeded without Atosiban,  . Our primary objective is Biochemical pregnancy rate which is determined by a positive urine pregnancy test or serum hCG> 20 mIU/ml measured 2 weeks after embryo transfer.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
23.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Previous atleast one implantation failure Adenomyosis.
  • by MUSA classification Grade A and B embryos.

排除标准

  • Hydrosalpinges on scan and untreated Moderate or severe endometriosis Abnormal Chromosome in either or both partners Fibroids.
  • FIGO 0,1,2 Uncorrected septate uterus.

结局指标

主要结局

Biochemical Pregnancy rate

时间窗: 5 weeks

次要结局

  • Implantation Rate(6 weeks of gestation)

研究者

发起方
Sree Supriya M
申办方类型
Private hospital/clinic
责任方
Principal Investigator
主要研究者

Sree Supriya M

A4 Hospital and Fertility centre

研究点 (1)

Loading locations...

相似试验